The reduced use of invasive procedures leads to a change of frequencies of prenatally detected chromosomal aberrations: population data from the years 2012-2016.

Chromosomal aberrations noninvasive prenatal testing prenatal diagnostics prenatal screening

Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Nov 2022
Historique:
pubmed: 26 11 2020
medline: 2 9 2022
entrez: 25 11 2020
Statut: ppublish

Résumé

The aim of the study was to analyze the results of screening for chromosomal aberrations in a population with a high rate of first-trimester screening and low rate of cell-free DNA testing. The data were obtained from the National Registry of Congenital Anomalies of the Czech Republic. We calculated and compared the proportion of autosomal trisomies (Down, Edwards, and Patau syndrome) and of other chromosomal aberrations identified during prenatal diagnostics. We identified 3009 prenatally diagnosed cases of chromosomal aberrations in the 2012-2016 period. The number of major autosomal trisomies has increased from 329 cases (30.86 per 10,000 live births) in 2012 to 423 cases (37.41) in 2016 ( Our population-based study confirmed a decrease in prenatal detection of nonmajor chromosomal aberrations wherein a decrease of invasive testing occurred. With the introduction of cell-free DNA testing, further decrease of invasive procedures and detection of nonmajor aberrations may be expected.

Identifiants

pubmed: 33233971
doi: 10.1080/14767058.2020.1849113
doi:

Substances chimiques

Cell-Free Nucleic Acids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4326-4331

Auteurs

Antonin Sipek (A)

Institute of Medical Biology and Genetics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Department of Medical Genetics, Thomayer Hospital, Prague, Czech Republic.
Institute of Biology and Medical Genetics, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.

Vladimir Gregor (V)

Department of Medical Genetics, Thomayer Hospital, Prague, Czech Republic.
Department of Medical Genetics, Pronatal Sanatorium, Prague, Czech Republic.

Antonin Sipek (A)

Department of Medical Genetics, Thomayer Hospital, Prague, Czech Republic.
Institute of Biology and Medical Genetics, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Department of Medical Genetics, Pronatal Sanatorium, Prague, Czech Republic.

Jan Klaschka (J)

Institute of Computer Science of the Czech Academy of Sciences, Prague, Czech Republic.
Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic.

Marek Maly (M)

Institute of Computer Science of the Czech Academy of Sciences, Prague, Czech Republic.
National Institute of Public Health, Prague, Czech Republic.

Pavel Calda (P)

Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH